Treatment or prevention of scarring, capsular contractures and/or hyperpigmentation using leukotriene receptor antagonist and vitamin E

Details for Australian Patent Application No. 2007227286 (hide)

Owner Schlesinger, L.

Inventors Schlesinger, Larry

Agent Davies Collison Cave

Pub. Number AU-A-2007227286

PCT Pub. Number WO2007/109248

Priority 60/783,398 20.03.06 US

Filing date 20 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 31/404 (2006.01)

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/355 (2006.01)

A61K 31/37 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/47 (2006.01) - Quinolines

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/109248 Priority application(s): WO2007/109248

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227289-Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases

2007227278-SIP receptor modulating compounds and use thereof